Osteopenia Completed Phase 4 Trials for Gliclazide (DB01120)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01679899Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityTreatment